Peer Review reports
From: Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis
| Original Submission | ||
|---|---|---|
| 8 Apr 2020 | Submitted | Original manuscript |
| 17 May 2020 | Reviewed | Reviewer Report |
| 8 Jun 2020 | Reviewed | Reviewer Report |
| 31 Jul 2020 | Author responded | Author comments - GIANCARLO COMI |
| Resubmission - Version 2 | ||
| 31 Jul 2020 | Submitted | Manuscript version 2 |
| 3 Aug 2020 | Reviewed | Reviewer Report |
| 9 Aug 2020 | Reviewed | Reviewer Report |
| 21 Aug 2020 | Author responded | Author comments - GIANCARLO COMI |
| Resubmission - Version 3 | ||
| 21 Aug 2020 | Submitted | Manuscript version 3 |
| 18 Sep 2020 | Author responded | Author comments - GIANCARLO COMI |
| Resubmission - Version 4 | ||
| 18 Sep 2020 | Submitted | Manuscript version 4 |
| Publishing | ||
| 23 Sep 2020 | Editorially accepted | |
| 6 Oct 2020 | Article published | 10.1186/s12883-020-01937-4 |
You can find further information about peer review here.